
Koninklijke Philips (NYSE: $PHG) reported its quarterly earnings, revealing a revenue of $4.81 billion, a decline of 1.13% year-over-year, which fell short of expectations by $149 million. The company also posted earnings per share (EPS) of $0.35, down 2.78% year-over-year, missing estimates by $0.03. Following the earnings report, Philips' stock experienced a significant drop, plummeting by 16% to 17% amid concerns over reduced full-year guidance, primarily attributed to a collapse in sales in China. CEO Roy Jakobs emphasized the company's commitment to innovation in the U.S., stating that it remains the company's top market, well-positioned to meet growing demand. The lowered sales target reflects a deteriorating demand from Chinese hospitals, contributing to investor unease about the company's future performance.
#China's top #aluminium maker #Chalco tumbled 12% in HK, Citi cut target price on weaker-than-expected Q3 performance https://t.co/5iAq81SYpM https://t.co/b6WlugMJX0
Philips’ investors can ill-afford another jolt to their nerves https://t.co/jm3ZqBHsZd | opinion
[Recap] Dutch medical device maker Philips lowered Monday its full year sales target, blaming drop in demand from Chinese hospitals. https://t.co/ffCDcX8T68